Pharmaceutical lactam compositions for inhibition of erythrocyte and thrombocyte aggregation

US5373019A · kind A · utility

Assignee

• Boehringer Mannheim GmbH · DE

Inventors

• Harald Zilch · Mannheim, DE
• Alfred Mertens · Schriesheim, DE
• Wolfgang von der Saal · Rosenheim, DE
• Erwin Boehm · Ladenburg, DE
• Klaus Strein · Hemsbach, DE

Key dates

• Filing date: Jan 11, 1991
• Grant date: Dec 13, 1994
• Expiry date: Jan 11, 2011

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention provides compounds and pharmaceutical compositions containing indolones of the general formula: ##STR1## These indolones where n.dbd.o and the pharmaceutical compositions containing these compounds are used for the treatment of diseases in which erythrocyte and thrombocyte aggregation play an important part, especially for the inhibition of aggregation of these cells.